EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparison of Immune Activation and Gut Barrier Dysfunction Between Long COVID and HIV Infection

Ziad Koberssy iD, Joviane Daher iD, Jared C Durieux iD, Ornina Atieh, Jhony Baissary, Marc Abboud iD, Kate Ailstock, Morgan Cummings, Nicholas Funderburg iD, Grace A McComsey iD

The Journal of Infectious Diseases · 03.08.2026 · 234 (1) · 93-100

DOI: 10.1093/infdis/jiag146 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 31.03.2026. Verfasst von Ziad Koberssy und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: COVID-19, HIV Infections. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, Clinical and Translational Science Collaborative of Cleveland, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Human immunodeficiency virus (HIV) infection is characterized by persistent immune dysregulation and inflammation, with emerging evidence suggesting overlapping pathophysiological mechanisms with long coronavirus disease (COVID). Biomarkers of systemic inflammation and gut integrity may provide insight into shared and distinct pathways underlying these conditions. The status of the anti-inflammatory vitamin K may play a role in sustained inflammation in these conditions.

Methods

This cross-sectional study enrolled participants belonging to 1 of 3 groups: individuals with long COVID without HIV (n = 108); participants with HIV (PWH) virologically suppressed with no previous COVID-19 infection (n = 256); and controls without long COVID or HIV (n = 193). Plasma samples were analyzed for inflammatory, gut integrity biomarkers, and dephosphorylated-uncarboxylated matrix Gla protein (dp-ucMGP) as an established marker of vitamin K status. Associations were assessed using multivariable linear and logistic regression models adjusted for demographic, metabolic, and lifestyle covariates.

Results

In total, 557 participants were included. Long COVID was independently associated with elevated oxidized low-density lipoprotein (β = .39 vs HIV, β = .54 vs controls; P < .001 for both). PWH had higher odds of worse vitamin K status (odds ratio, 1.5; 95% CI, 1.02–2.2; P = .04). Independent of long COVID or HIV status, worse vitamin K status was strongly associated with higher levels of inflammatory markers.

Conclusions

Long COVID and HIV share chronic immune dysregulation features but demonstrate distinct inflammatory profiles. These findings highlight the importance of large longitudinal studies to delineate shared versus unique inflammatory pathways to guide potential long COVID therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HIV InfectionsHumansFemaleMaleCross-Sectional StudiesPost-Acute COVID-19 SyndromeMiddle AgedBiomarkersSARS-CoV-2AdultMatrix Gla ProteinLipoproteins, LDLIntestinal Barrier FunctionInflammationExtracellular Matrix ProteinsCalcium-Binding ProteinsVitamin K

Stichwörter der Autor:innen

dephosphorylated-uncarboxylated matrix Gla protein (dp-ucMGP)human immunodeficiency virus (HIV)long COVIDoxidized LDLvitamin K

Substanzen

BiomarkersMatrix Gla ProteinLipoproteins, LDLExtracellular Matrix Proteinsoxidized low density lipoproteinCalcium-Binding ProteinsVitamin K

Autor:innen und Institutionen

  • School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
  • Clinical Research Center, University Hospitals, Cleveland Medical Center, Cleveland, Ohio, USA.
  • Faculty of Medicine, Saint Joseph Medical School, Beirut, Lebanon.
  • Division of Medical Laboratory Science, School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, Ohio, USA.

ORCID-Profile: Ziad Koberssy, Joviane Daher, Jared C Durieux, Marc Abboud, Nicholas Funderburg, Grace A McComsey

Förderung

  • NCATS NIH HHS
  • Clinical and Translational Science Collaborative of Cleveland
  • NIH HHS
  • Case Western Reserve University
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Koberssy, Z., Daher, J., Durieux, J. C., Atieh, O., Baissary, J., Abboud, M., Ailstock, K., Cummings, M., Funderburg, N., & McComsey, G. A. (2026). Comparison of Immune Activation and Gut Barrier Dysfunction Between Long COVID and HIV Infection. The Journal of Infectious Diseases, 234(1), 93-100. https://doi.org/10.1093/infdis/jiag146

Vancouver

Koberssy Z, Daher J, Durieux JC, Atieh O, Baissary J, Abboud M, et al. Comparison of Immune Activation and Gut Barrier Dysfunction Between Long COVID and HIV Infection. The Journal of Infectious Diseases. 2026;234(1):93-100. doi:10.1093/infdis/jiag146

BibTeX
@article{Koberssy2026,
  author = {Koberssy, Ziad and Daher, Joviane and Durieux, Jared C and Atieh, Ornina and Baissary, Jhony and Abboud, Marc and Ailstock, Kate and Cummings, Morgan and Funderburg, Nicholas and McComsey, Grace A},
  title = {Comparison of Immune Activation and Gut Barrier Dysfunction Between Long COVID and HIV Infection},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  volume = {234},
  number = {1},
  pages = {93--100},
  doi = {10.1093/infdis/jiag146}
}
Kostenlos starten →